Skip to main content
Clinical Trials/CTRI/2022/11/047398
CTRI/2022/11/047398
Recruiting
Phase 2

A controlled comparative clinical study to evaluate the bronchodilator effect of parnayavani arka nebulisation in wheezing children

Parul Institute of Ayurved0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: J22- Unspecified acute lower respiratory infection
Sponsor
Parul Institute of Ayurved
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Parul Institute of Ayurved

Eligibility Criteria

Inclusion Criteria

  • Patients of either sex.
  • Patients between age group of 6\-14 years
  • Patients having wheezing on chest auscultation
  • Patients consenting to be included in the study

Exclusion Criteria

  • Known case of tuberculosis or any other acute and grave infection.
  • Patients with history of malignancy
  • Patients with congenital anatomical abnormalities of chest and respiratory system
  • Patients in life\- threatening conditions viz,\- respiratory acidosis, diabetic ketoacidosis, Respiratory Distress Syndrome etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials